SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Arvind Remedies reports 11% rise in Q1 net profit

18 Aug 2012 Evaluate

Arvind Remedies has reported results for first quarter ended June 30, 2012.

On standalone basis, the company has reported a rises of 10.68% in its net profit at Rs 9.12 crore for the quarter, as compared to Rs 8.24 crore for the same quarter in the previous year. Total income of the company has increased by 29.98% to Rs 139.72 crore for the quarter under review as compared to Rs 107.49 crore for the quarter ended June 30, 2011.

Arvind Remedies is engaged in manufacturing of pharmaceutical formulations such as tablets, capsules (including soft gels), ointments and liquids. It has a manufacturing facility at Kakkalur in Tamil Nadu.

Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×